跳到正文
原文
Nature 综合主刊· Gregory P. Donaldson·· 9 天前AI 评分35

Suppression of epithelial proliferation and tumorigenesis by IgA

Suppression of epithelial proliferation and tumorigenesis by IgA

AI 导读

研究数据表明,IgA(免疫球蛋白A)通过抑制上皮细胞增殖和肿瘤发生,在肠道微生物稳态中发挥关键作用。所有相关数据可在NCBI Sequence Read Archive (SRA) 下载。

正文

Data availability

All raw sequencing data for bulk RNA-seq, 16S rRNA amplicon sequencing and single-cell RNA-seq are available via the NCBI Sequence Read Archive (SRA) under a unified project: PRJNA1023250. The following freely accessible databases were also used: UniProt (https://uniprot.org), Tabula muris and Tabula sapiens (https://biohub.org) and GSEA gene sets (https://gsea-msigdb.org). Source data are provided with this paper.

References

  1. Fagarasan, S. Evolution, development, mechanism and function of IgA in the gut. Curr. Opin. Immunol. 20, 170–177 (2008).

    Article  CAS  PubMed  Google Scholar 

  2. Pabst, O. & Slack, E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol. 13, 12–21 (2020).

    Article  CAS  PubMed  Google Scholar 

  3. Huus, K. E., Petersen, C. & Finlay, B. B. Diversity and dynamism of IgA−microbiota interactions. Nat. Rev. Immunol. 21, 514–525 https://doi.org/10.1038/s41577-021-00506-1 (2021).

    Article  CAS  PubMed  Google Scholar 

  4. Catanzaro, J. R. et al. IgA-deficient humans exhibit gut microbiota dysbiosis despite secretion of compensatory IgM. Sci. Rep. 9, 13574 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Yel, L. Selective IgA deficiency. J. Clin. Immunol. 30, 10–16 https://doi.org/10.1007/s10875-009-9357-x (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fadlallah, J. et al. Microbial ecology perturbation in human IgA deficiency. Sci. Transl. Med. 10, eaan1217 (2018).

    Article  PubMed  Google Scholar 

  7. Conrey, P. E. et al. IgA deficiency destabilizes homeostasis toward intestinal microbes and increases systemic immune dysregulation. Sci. Immunol. 8, eade2335 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Moll, J. M. et al. Gut microbiota perturbation in IgA deficiency is influenced by IgA-autoantibody status. Gastroenterology 160, 2423–2434 https://doi.org/10.1053/j.gastro.2021.02.053 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Shroff, K. E., Meslin, K. & Cebra, J. J. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63, 3904–3913 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Singh, K., Chang, C. & Gershwin, M. E. IgA deficiency and autoimmunity. Autoimmun. Rev. 13, 163–177 (2014).

    Article  CAS  PubMed  Google Scholar 

  11. Ludvigsson, J. F., Neovius, M., Ye, W. & Hammarström, L. IgA deficiency and risk of cancer: a population-based matched cohort study. J. Clin. Immunol. 35, 182–188 (2015).

    Article  CAS  PubMed  Google Scholar 

  12. Langford, T. D. et al. Central importance of immunoglobulin A in host defense against Giardia spp. Infect. Immun. 70, 11–18 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Blutt, S. E., Miller, A. D., Salmon, S. L., Metzger, D. W. & Conner, M. E. IgA is important for clearance and critical for protection from rotavirus infection. Mucosal Immunol. 5, 712–719 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Moor, K. et al. High-avidity IgA protects the intestine by enchaining growing bacteria. Nature 544, 498–502 (2017).

    Article  CAS  PubMed  Google Scholar 

  15. Jørgensen, S. F. et al. Selective IgA deficiency in humans is associated with reduced gut microbial diversity. J. Allergy Clin. Immunol. 143, 1969–1971(2019).

    Article  PubMed  Google Scholar 

  16. Gatti, R. A. & Good, R. A. Occurrence of malignancy in immunodeficiency diseases: a literature review. Cancer 28, 89–98 (1971).

    Article  CAS  PubMed  Google Scholar 

  17. Filipovich, A. H., Mathur, A., Kamat, D., Kersey, J. H. & Shapiro, R. S. Lymphoproliferative disorders and other tumors complicating immunodeficiencies. Immunodeficiency 5, 91–112 (1994).

    CAS  PubMed  Google Scholar 

  18. Ludvigsson, J. F., Neovius, M. & Hammarström, L. IgA deficiency & mortality: a population-based cohort study. J. Clin. Immunol. 33, 1317–1324 (2013).

    Article  CAS  PubMed  Google Scholar 

  19. Cunningham-Rundles, C., Pudifin, D. J., Armstrong, D. & Good, R. A. Selective IgA deficiency and neoplasia. Vox Sang. 38, 61–67 (1980).

    CAS  PubMed  Google Scholar 

  20. Pulvirenti, F. et al. Gastric cancer is the leading cause of death in Italian adult patients with common variable immunodeficiency. Front. Immunol. 9, 2546 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  21. Shulzhenko, N. et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585–1593 (2011).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kawamoto, S. et al. The inhibitory receptor PD-1 regulates IgA selection and bacterial composition in the gut. Science 336, 485–489 (2012).

    Article  CAS  PubMed  Google Scholar 

  23. Kubinak, J. L. et al. MyD88 signaling in T cells directs IgA-mediated control of the microbiota to promote health. Cell Host Microbe 17, 153–163 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Suzuki, K. et al. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc. Natl Acad. Sci. USA 101, 1981–1986 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Fagarasan, S. et al. Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora. Science 298, 1424–1427 (2002).

    Article  CAS  PubMed  Google Scholar 

  26. Gopalakrishna, K. P. et al. Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants. Nat. Med. 25, 1110–1115 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kawamoto, S. et al. Foxp3+ T cells regulate immunoglobulin a selection and facilitate diversification of bacterial species responsible for immune homeostasis. Immunity 41, 152–165 (2014).

    Article  CAS  PubMed  Google Scholar 

  28. Nagashima, K. et al. Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. Nat. Immunol. 18, 675–682 (2017).

    Article  CAS  PubMed  Google Scholar 

  29. Peterson, D. A. et al. Characterizing the interactions between a naturally primed immunoglobulin A and its conserved Bacteroides thetaiotaomicron species-specific epitope in gnotobiotic mice. J. Biol. Chem. 290, 12630–12649 https://doi.org/10.1074/jbc.m114.633800 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Nakajima, A. et al. IgA regulates the composition and metabolic function of gut microbiota by promoting symbiosis between bacteria. J. Exp. Med. 215, 2019–2034 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Donaldson, G. P. et al. Gut microbiota utilize immunoglobulin A for mucosal colonization. Science 360, 795–800 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rollenske, T. et al. Parallelism of intestinal secretory IgA shapes functional microbial fitness. Nature 598, 657–661 https://doi.org/10.1038/s41586-021-03973-7 (2021).

    Article  CAS  PubMed  Google Scholar 

  33. Harriman, G. R. et al. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 162, 2521–2529 (1999).

    Article  CAS  PubMed  Google Scholar 

  34. Murthy, A. K., Dubose, C. N., Banas, J. A., Coalson, J. J. & Arulanandam, B. P. Contribution of polymeric immunoglobulin receptor to regulation of intestinal inflammation in dextran sulfate sodium-induced colitis. J. Gastroenterol. Hepatol. 21, 1372–1380 (2006).

    Article  CAS  PubMed  Google Scholar 

  35. Mathias, A. & Corthésy, B. N-Glycans on secretory component: mediators of the interaction between secretory IgA and gram-positive commensals sustaining intestinal homeostasis. Gut Microbes 2, 287–293 (2011).

    Article  PubMed  Google Scholar 

  36. Kaetzel, C. S. The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol. Rev. 206, 83–99 (2005).

    Article  CAS  PubMed  Google Scholar 

  37. Ramanan, D. et al. An immunologic mode of multigenerational transmission governs a gut Treg setpoint. Cell 181, 1276–1290 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. van der Post, S., Birchenough, G. M. H. & Held, J. M. NOX1-dependent redox signaling potentiates colonic stem cell proliferation to adapt to the intestinal microbiota by linking EGFR and TLR activation. Cell Rep. 35, 108949 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  39. Grivennikov, S. I. et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491, 254–258 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Ansari, Y. S. E. et al. T follicular helper cell expansion and hyperimmunoglobulinemia with spontaneous IgE production to dietary antigens in IgA-deficient mice. Mucosal Immunol. 18, 481–490 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  41. Clay, S. L., Fonseca-Pereira, D. & Garrett, W. S. Colorectal cancer: the facts in the case of the microbiota. J. Clin. Invest. 132, e155101 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Donaldson, G. P., Lee, S. M. & Mazmanian, S. K. Gut biogeography of the bacterial microbiota. Nat. Rev. Microbiol. 14, 20–32 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  43. Beumer, J. & Clevers, H. Cell fate specification and differentiation in the adult mammalian intestine. Nat. Rev. Mol. Cell Biol. 22, 39–53 (2021).

    Article  CAS  PubMed  Google Scholar 

  44. Tsang, D. K. L. et al. A single cell survey of the microbial impacts on the mouse small intestinal epithelium. Gut Microbes 14, 2108281 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  45. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229–241 (2004).

    Article  CAS  PubMed  Google Scholar 

  46. Rundegren, J. & Arnold, R. R. Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains. Infect. Immun. 55, 288–292 (1987).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Mollenhauer, J. et al. The genomic structure of the DMBT1gene: evidence for a region with susceptibility to genomic instability. Oncogene 18, 6233–6240 (1999).

    Article  CAS  PubMed  Google Scholar 

  48. Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).

    Article  PubMed  Google Scholar 

  49. Madsen, J. et al. CRP-ductin, the mouse homologue of gp-340/deleted in malignant brain tumors 1 (DMBT1), binds gram-positive and gram-negative bacteria and interacts with lung surfactant protein D. Eur. J. Immunol. 33, 2327–2336 (2003).

    Article  CAS  PubMed  Google Scholar 

  50. Reichhardt, M. P. et al. The salivary scavenger and agglutinin in early life: diverse roles in amniotic fluid and in the infant intestine. J. Immunol. 193, 5240–5248 (2014).

    Article  CAS  PubMed  Google Scholar 

  51. Hopkins, E. G. D., Roumeliotis, T. I., Mullineaux-Sanders, C., Choudhary, J. S. & Frankel, G. Intestinal epithelial cells and the microbiome undergo swift reprogramming at the inception of colonic Citrobacter rodentium infection. mBio 10, e00062-19 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  52. Müller, H., Nagel, C., Weiss, C., Mollenhauer, J. & Poeschl, J. Deleted in malignant brain tumors 1 (DMBT1) elicits increased VEGF and decreased IL-6 production in type II lung epithelial cells. BMC Pulm. Med. 15, 32 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  53. Fre, S. et al. Notch signals control the fate of immature progenitor cells in the intestine. Nature 435, 964–968 (2005).

    Article  CAS  PubMed  Google Scholar 

  54. van Es, J. H. et al. Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959–963 (2005).

    Article  PubMed  Google Scholar 

  55. The Tabula Muris Consortium. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367–372 (2018).

    Article  CAS  Google Scholar 

  56. The Tabula Sapiens Consortium. The Tabula Sapiens: a multiple-organ, single-cell transcriptomic atlas of humans. Science 376, eabl4896 (2022).

    Article  Google Scholar 

  57. Kabatnik, S. et al. Spatial characterization and stratification of colorectal adenomas by deep visual proteomics. iScience 27, 110620 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Tang, Y. et al. MZB1-mediated IgA secretion suppresses the development and progression of colorectal cancer triggered by gut inflammation. Mucosal Immunol. 17, 450–460 https://doi.org/10.1016/j.mucimm.2023.12.002 (2024).

    Article  CAS  PubMed  Google Scholar 

  59. Biswas, S. et al. IgA transcytosis and antigen recognition govern ovarian cancer immunity. Nature 591, 464–470 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Pelka, K. et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell 184, 4734–4752 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Dogan, I. et al. Multiple layers of B cell memory with different effector functions. Nat. Immunol. 10, 1292–1299 (2009).

    Article  CAS  PubMed  Google Scholar 

  62. Robertson, S. J. et al. Comparison of co-housing and littermate methods for microbiota standardization in mouse models. Cell Rep. 27, 1910–1919 (2019).

    Article  CAS  PubMed  Google Scholar 

  63. Quadros, R. M. et al. Easi-CRISPR: a robust method for one-step generation of mice carrying conditional and insertion alleles using long ssDNA donors and CRISPR ribonucleoproteins. Genome Biol. 18, 92 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  64. Dmitrieva-Posocco, O. et al. β-Hydroxybutyrate suppresses colorectal cancer. Nature 605, 160–165 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Brugiroux, S. et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat. Microbiol. 2, 16215 (2016).

    Article  CAS  PubMed  Google Scholar 

  66. Mandal, S. et al. Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb. Ecol. Health Dis. 26, 27663 (2015).

    PubMed  PubMed Central  Google Scholar 

  67. Earley, Z. M. et al. GATA4 controls regionalization of tissue immunity and commensal-driven immunopathology. Immunity 56, 43–57 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Bharathkar, S. K. et al. The structures of secretory and dimeric immunoglobulin A. eLife 9, e56098 (2020).

    Article  CAS  Google Scholar 

  69. Dreyfus, C. et al. Highly Conserved Protective Epitopes on Influenza B Viruses. Science 337, 1343–1348 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Miyoshi, H. & Stappenbeck, T. S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8, 2471–2482 (2013).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Roper, J. et al. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis. Nat. Biotechnol. 35, 569–576 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank J. Faith, D. Wesemann, M. Koch, N. Palm, L. Mesin and members of the D.M. and G.D.V. laboratories at the Rockefeller University for discussions. S. Leonard assisted with protein purifications. Germ-free mice were generated and maintained by A. Rogoz. Dmbt1 transmembrane-knockout mice were generated by J. Bortolatto. All mice were monitored and cared for by the staff of the Comparative Bioscience Center at the Rockefeller University. Sequencing was performed at the Genomics Resource Center of the Rockefeller University (RRID:SCR_020986). Proteomics data were generated by the Proteomics Resource Center at the Rockefeller University (RRID:SCR_017797), with assistance from H. Molina, using instrumentation funded by the Sohn Conferences Foundation and the Leona M. and Harry B. Helmsley Charitable Trust. Microscale electrophoresis was performed at the Fisher Drug Discovery Resource Center at the Rockefeller University (RRID:SCR_020985), with assistance from J. F. Glickman.

Funding

G.P.D. was a Robert Black Fellow of the Damon Runyon Cancer Research Foundation (DRG-2362-19). G.L.d.R. was supported by a scholarship from Fundação Maria Emília. C.W. was supported by the German Academic Scholarship Foundation. Project initiation was supported by pilot grants to G.P.D. from the Rockefeller University Center for Basic and Translational Research on Disorders of the Digestive System through the Leona M. and Harry B. Helmsley Charitable Trust and the Shapiro-Silverberg Fund for the Advancement of Translational Research. K.B. is supported by the NIH/NCI (1R01CA308066-01A1), NIH/NCI (5U54CA261701) and Weill Cancer Hub East. S.F.T. is supported by grants from NCI (R35CA274446, U54CA261701 and R01CA257153) and the Marlene Hess Center for Research on Women’s Health and Biomedicine. The overall project was funded by grants from the NIH to S.I.G. (R01CA218133), to B.M.S. (R01AI165570), to G.D.V. and D.M. (R01AI157137) and to D.M. (U54CA261701). D.M. is supported by a CZI Immune Cell Engineering Award and by Weill Cancer Hub East. G.D.V. and D.M. are investigators of the Howard Hughes Medical Institute.

Author information

Author notes

  1. Gregory P. Donaldson

    Present address: Department of Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles, Los Angeles, CA, USA

Authors and Affiliations

  1. Laboratory of Mucosal Immunology, The Rockefeller University, New York, NY, USA

    Gregory P. Donaldson, Gabriella Lima dos Reis, Marwa Saad, Christopher Wichmann, Izabela Mamede, Guo Chen, Caroline E. Harrer, Begüm Aydin, Bernardo S. Reis & Daniel Mucida

  2. Laboratory of Lymphocyte Dynamics, The Rockefeller University, New York, NY, USA

    Christopher Wichmann, Tiago B. R. Castro & Gabriel D. Victora

  3. Laboratory of Metabolic Regulation and Genetics, The Rockefeller University, New York, NY, USA

    Nicole L. DelGaudio & Kivanç Birsoy

  4. Department of Biochemistry, University of Illinois, Urbana, IL, USA

    Dayu Zhang & Beth M. Stadtmueller

  5. Departments of Medicine and Biomedical Sciences, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Sergei I. Grivennikov

  6. Section of Rheumatology, Allergy and Immunology, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA

    Elise G. Liu

  7. Division of Allergy and Immunology, Department of Medicine, and Center for Human Immunobiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

    Stephanie C. Eisenbarth

  8. Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA

    Sohail F. Tavazoie

  9. Carl R. Woese Institute for Genomic Biology and Department of Biomedical and Translational Sciences, Carle Illinois College of Medicine, University of Illinois, Urbana, IL, USA

    Beth M. Stadtmueller

  10. Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA

    Gabriel D. Victora & Daniel Mucida

Authors

  1. Gregory P. Donaldson
  2. Gabriella Lima dos Reis
  3. Marwa Saad
  4. Christopher Wichmann
  5. Izabela Mamede
  6. Guo Chen
  7. Caroline E. Harrer
  8. Nicole L. DelGaudio
  9. Dayu Zhang
  10. Begüm Aydin
  11. Tiago B. R. Castro
  12. Sergei I. Grivennikov
  13. Bernardo S. Reis
  14. Elise G. Liu
  15. Stephanie C. Eisenbarth
  16. Kivanç Birsoy
  17. Sohail F. Tavazoie
  18. Beth M. Stadtmueller
  19. Gabriel D. Victora
  20. Daniel Mucida

Contributions

G.P.D. and D.M. conceived and initiated the project. G.P.D. designed and performed most of the experiments, with guidance from D.M. G.L.d.R. performed organoid experiments, purified IgA, performed the pull-down assay and assisted with most of the experiments. M.S. performed the colonoscopy procedures and cultured organoids. C.W. performed tissue culture and biochemical binding experiments. G.P.D. analysed 16S rRNA amplicon sequencing data, I.M. analysed single-cell RNA-seq data and G.C. analysed bulk RNA-seq data, with guidance and analysis oversight from T.B.R.C. N.L.D. assisted with flow cytometry and tissue culture experiments. C.E.H. performed plasma-cell flow cytometry and assisted with fluorescence imaging. D.Z. and B.M.S. designed and produced recombinant SC and IgA variants. G.P.D., B.A. and B.S.R. designed and performed epithelial cell sorting and single-cell transcriptomics. S.I.G. and B.S.R. advised on and assisted with mouse models of colorectal cancer. E.G.L. and S.C.E. provided the 2025 IgA-knockout mouse and designed and performed cancer experiments. K.B., S.F.T., B.M.S., G.D.V. and D.M. supervised, guided experimental design and directed interpretation of results. G.P.D. and D.M. wrote the manuscript, and all authors edited it.

Corresponding authors

Correspondence to Gregory P. Donaldson or Daniel Mucida.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature thanks Sidonia Fagarasan, Thaddeus Stappenbeck and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data figures and tables

Extended Data Fig. 1 Further data related to the IgA-knockout model and the APC-driven colorectal cancer model.

a, ELISA of faecal IgA in homozygotes and heterozygotes of the IgA−/− strain crossed with C57BL6/J (n = 8, 8, 4). b, Breeding scheme for littermate controls. c,d, ELISA of faecal IgG (c) and IgM (d) in littermates from this breeding scheme (n = 9,7). e, Combined visualization of faecal antibody isotype ELISA data from the IgA+/− mice in c,d (n = 9, statistics not used). f, Differentially expressed genes in bulk RNA-seq from mid-colon tissue of IgA+/− and IgA−/− littermates fourteen days after inducing colon epithelial-specific loss of Apc (n = 4). g, Set of genes identified as modulated by both Apc loss (steady state versus APC day 14 comparison) and IgA deficiency at steady state (IgA+/− vs. IgA−/−). Notably, the direction of the effect of IgA deficiency is toward the direction caused by Apc loss (n = 5, 5, 4, 4). h, End-point analyses of the APC-driven cancer model using IgA+/+ and IgA+/− littermates (n = 4). i, ELISA for faecal lipocalin in the APC-driven cancer model (n = 3, from one cohort, representative, repeated-measures 2-way ANOVA not significant). j, Cytokine gene expression in the bulk colon tissue RNA-seq shows no IgA-dependent alterations in inflammatory pathways (n = 5, 5, 4, 4) (mean and SEM, t-tests unless otherwise stated, p values hidden when p > 0.1). Illustration in b adapted from OpenClipArt (Lemmling) under a CC0 1.0 licence.

Source data

Extended Data Fig. 2 Immune profiling of normal colon lamina propria and tumour-containing tissue shows no IgA-dependent differences in co-housed littermates.

a, Gating strategy for innate and adaptive immune profiling of major colon-relevant subpopulations. b,c, Innate (b) and adaptive (c) cell populations in colon lamina propria (top row) or Apc-mutation-induced endogenous tumours (bottom row) isolated from IgA+/− and IgA−/− littermates (n = 4, pooled two independent experiments for healthy mice and n = 5, 4, pooled two independent experiments for tumours) (mean and SEM, t-tests, p values hidden when p > 0.1).

Source data

Extended Data Fig. 3 Further data related to various IgA deficiency models and colon cancer models.

a, Body weight change during AOM-DSS (n = 4, from one cohort, representative). b, Tumour frequency in the AOM-DSS cancer model (n = 9, 8) (t-tests unless otherwise stated, p values hidden when p > 0.1). c–e, Colon length, tumour count, and average tumour size outcomes in AOM-DSS for 1999 IgA−/− mice (c; as in Fig. 1j, pooled 2 cohorts, n = 9, 8 except mice without tumours excluded from average tumour size figure: n = 3, 7), 2025 BALB/c IgA−/− mice (d; as in Fig. 1k, pooled 2 cohorts, n = 9, 20), and AID−/− mice (e; as in Fig. 1l, representative of 2 cohorts, n = 8, 7). f, Representative images of colons with tumours from AID−/− mice at end point of AOM-DSS (representative of 2 cohorts, n = 8, 7). g, Schematic showing differences in general tumour localization in the three colorectal cancer models used in this work. (mean and SEM, t-tests, p values hidden when p > 0.1).

Source data

Extended Data Fig. 4 Microbiome profiling data.

a, ELISA for IgA in faeces of IgA+/− mice before and after antibiotics treatment as in Fig. 2b and in mice colonized with oligo-mm12 as in Fig. 2e (n = 5) (mean and SEM, one-way ANOVA, p values hidden when p > 0.1). b, Beta diversity (weighted unifrac distance) of microbiome measured by 16S rRNA amplicon sequencing of samples from IgA+/− (blue) and IgA−/− (red) mice showing no genotype-specific alterations (lumen n = 9, 6, 7, 6, mucus n = 4, 8, 7, 6). c, Heat map of ASVs (columns) identified in colon mucus samples from indicated mice (rows) demonstrates dramatic shift caused by Apc loss, but no effect of IgA. d, Relative abundance of ASVs identified by 16S rRNA amplicon sequencing of faeces from IgA+/− and IgA−/− littermates before and after AOM-DSS treatment (n = 5, 4, 4, 3). e, Relative abundance of ASVs identified by 16S rRNA amplicon sequencing of faeces from wild-type C57BL/6j mice before and two weeks after a two-dose tamoxifen treatment that matches the induction protocol used to knock out Apc in Fig. 1d–h demonstrates that the microbiome shift observed is not due to tamoxifen injection (n = 5).

Source data

Extended Data Fig. 5 Further results related to IgA gavage treatments.

a, Gating strategy for flow cytometry for IgA coating of bacterial cells in faecal samples and summary data showing a lack of IgA binding to bacteria when IgA−/− mice were gavaged with faecal IgA purified from germ-free mice mono-colonized with Bacteroides fragilis (n = 5, 3, 4). b–e, Counts and sizes of tumours from IgA−/− mice treated with faecal extracts (b; n = 6, 7), purified faecal IgA from SPF mice (c; n = 4, 5), purified faecal IgA from mice mono-colonized with Bacteroides fragilis (d; n = 6) or recombinant CR9114 anti-influenza HA monoclonal SIgA (e; n = 3, 5) (mean and SEM, t-tests or one-way ANOVA, p values hidden when p > 0.1).

Source data

Extended Data Fig. 6 Further data related to colon epithelial single-cell RNA-seq.

a, Gating strategy for sorting live EPCAM + , CD45- epithelial cells for single-cell transcriptomics (n = 3). b, Various markers to aid in identifying clusters: Lgr5 (stem), Nox1 (transit-amplifying), Mki67 (cycling), Hao2 (immature), Muc2 (low: mature, high: goblet), Neurod1 (enteroendocrine), Dclk1 (Tuft), and Epcam (pan-epithelial). c, Expression level of Reg3g, Reg3b, and Dmbt1 in all cells. d, Full version of Fig. 3g with all clusters: Gene set enrichment analyses in individual clusters based on IgA genotype. Dots are visible where adjusted p value < 0.05, size of dot represents the number of genes int he pathway, and colour represents the normalized enrichment score of that pathway (IgA−/−-enriched is positive, red). e, Dmbt1 reads across cell types.

Extended Data Fig. 7 Further data related to epithelial proliferation.

a, EdU (pink) and EPCAM (green) staining in germ-free mice after two injections (−24 h and −4 h) of EdU showed no difference between IgA+/− and IgA−/− littermates (n = 4). b, Primary mouse colon organoids were cultured from isolated crypts in the presence of indicated antibody isotypes imaged by brightfield microscopy. Organoid counting from four independent experiments pooled and normalized to the IgG treatment control (n = 5, 20, 19). c, Flow cytometry of surface DMBT1 on Expi293 cells: wild-type (left) and expressing a membrane isoform of Dmbt1 (right), with summary data graphed (n = 5 independent transfections). d, Gating strategy for transfected Expi293 cells that are live and have a FLAG tag marking transgene expression. e, Binding of Expi293 cells to different antibody structures was dependent on transfection with the Dmbt1 expression construct and also dependent on FLAG tag expression marking surface DMBT1 protein (n = 5 independent transfections performed over 3 independent experiments). f, SIgA regulation of CMT-93 cell growth was not dependent on Hes1 gene (n = 4, 4, 5, 5). g, Experimental design for Notch inhibition to suppress epithelial proliferation in the context of IgA deficiency and Apc loss (mean and SEM, t-tests or one-way ANOVA, p values hidden when p > 0.1).

Source data

Extended Data Fig. 8 Further data on the transmembrane Dmbt1-knockout mouse model.

a, DNA gel showing knockout of 182 bp in the last exon of mouse Dmbt1 and the sequence-confirmed knockout on mouse genome (green track) (original gel of two individual founder mice). b, Gating strategy for plasma cells in the colon lamina propria. c, Total plasma cells and IgA+ (bottom row) plasma cells in Dmbt1+/− and Dmbt1−/− littermate mice. d, Quantification of total plasma cells and e, IgA+ plasma cells (n = 6, 5, pooled two independent experiments). f, Faecal IgA levels quantified by ELISA in Dmbt1+/− and Dmbt1−/− littermate mice (2 cohorts pooled, n = 6, 5). g, Colon lamina propria plasma cells do not express DMBT1 (mean and SEM, t-tests).

Source data

Extended Data Fig. 9 Further data related to the association of DMBT1 with physiological epithelial proliferation and the decoupling of DMBT1 and Notch during tumorigenesis.

a,b, Single-cell expression of Dmbt1 across mouse tissues (a) and human tissues (b) reveals remarkable conservation and specificity to epithelial cell subsets. c, Plot of proliferating epithelial cells to directly compare germ-free and SPF mice from Fig. 5a (n = 5). d,e, Flow cytometry analysis (d) of DMBT1 and Ki67 in colon epithelial cells isolated from IgA+/− and IgA−/− littermate mice demonstrates increased DMBT1 in IgA−/− mice (e), consistent with single-cell RNA-seq in Fig. 3a–f (pooled two cohort, n = 6). f, Increased proliferation of epithelial cells in IgA−/− mice occurs amongst cells that are DMBT1+ (same mice as e). g, Relative contribution of each time point to clusters in single-cell RNA-Seq analysis in Fig. 5. Cluster 2, absent prior to Apc knockout, represents the transformed tumour cells. h, Differential expression across clusters (Fig. 5e), reveals that the tumour cells (cluster 2) lose epithelial identity and dramatically lose Dmbt1 expression. (mean and SEM, t-tests, p values hidden when p > 0.1).

Source data

Extended Data Table 1 Microscale electrophoresis of purified DMBT1 protein and antibodies

Full size table

Supplementary information

Supplementary Information (download PDF )

Supplementary Fig. 1, descriptions for Supplementary Data 1–5, Supplementary Discussion and Supplementary References.

Reporting Summary (download PDF )

Supplementary Data 1 (download XLSX )

Steady-state bulk RNA-seq. List of genes and associated statistics for those up- and downregulated depending on IgA genotype during steady state (no cancer model), as shown in Fig. 1.

Supplementary Data 2 (download XLSX )

Apc day 14 bulk RNA-seq. List of genes and associated statistics for those up- and downregulated depending on IgA genotype 2 weeks after loss of Apc in epithelial cells (cancer model, pre-tumour), as shown in Fig. 1.

Supplementary Data 3 (download XLSX )

Steady-state single-cell RNA-seq. List of genes and associated statistics for those up- and downregulated by IgA knockout (positive fold change = higher in IgA knockout) across all cells and within each cluster of the colon epithelial single-cell RNA-seq experiment in Fig. 3.

Supplementary Data 4 (download XLSX )

Mass-spectrometry data of IgA pull-down from organoid lysates. List of peptides and associated statistics for those enriched in pull-down with IgA (versus control without IgA), showing mostly Ig-related peptides as expected, with a few notable hits (including the identification of DMBT1).

Supplementary Data 5 (download XLSX )

Primers and guide RNAs. List of primers used in the study for PCR and guide RNAs for cell line and mouse knockouts.

Peer Review File (download PDF )

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donaldson, G.P., Lima dos Reis, G., Saad, M. et al. Suppression of epithelial proliferation and tumorigenesis by IgA. Nature (2026). https://doi.org/10.1038/s41586-026-11264-2

Download citation

  • Received: 06 October 2023

  • Accepted: 06 October 2026

  • Published: 11 November 2026

  • Version of record: 11 November 2026

  • DOI: https://doi.org/10.1038/s41586-026-11264-2

来源:Nature 综合主刊 · nature.com